Texas DSHS HIV/STD Program - Texas HIV Medication Program

THMP Moving Forward Together Partnership

The Texas HIV Medication Program (THMP) provides medications for the treatment of HIV and its related complications for low-income Texans. To qualify for medications, potential clients who meet eligibility criteria complete an application for assistance. Once approved, a client receives medications at an assigned pharmacy in their community.

To learn more about the THMP and find out if you are eligible, see the Frequently Asked Questions. You can apply for the program by downloading and completing the client application. Be sure and review the specific “application instructions” when completing the application. The application and its instructions are located on the THMP document page. If you have more questions or need assistance completing your application, call the THMP toll free at 1-800-255-1090.

The THMP is the official AIDS Drug Assistance Program (ADAP) for the State of Texas. The THMP has been in existence since 1987 and provides medications approved by the Food and Drug Administration (FDA) for the treatment of illnesses caused by the human immunodeficiency virus (HIV) and other opportunistic infections in HIV-infected individuals as prescribed by their doctor. THMP also operates the Texas HIV State Pharmaceutical Assistance Program (SPAP) which helps HIV-positive individuals that do not qualify for the full Low-Income Subsidy (extra help) with their out-of-pocket costs associated with Medicare Part D prescription drug plans, including co-payments, deductibles, coinsurance, and during the coverage gap (the "donut hole").

Texas HIV Medication Program Medication Advisory Committee Meeting

AGENDA
July 30, 2021
1:30 p.m.

Meeting Site: Microsoft Office Teams Live Event
Due to the COVID-19 pandemic, this meeting will be conducted online using Microsoft Teams only. To join the meeting, go to: https://texashhsmeetings.org/HIVMAC_July2021.

There is not a physical location for this meeting.

Closed captioning for this meeting is available. Viewers are asked to highlight the closed captioning symbol "cc" on the bottom of their viewing screen to enable this function.

Attendees who would like to provide public comment should see the Public Comment section below.

Call to Order, Welcome and Opening Remarks – Natalie Vanek, M.D., Committee Chair
Logistical Announcement and Roll Call – Sallie Allen, Advisory Committee Coordination Office, HHSC
Consideration of January 29, 2021 and April 30, 2021, meeting minutes – Sallie Allen, Advisory Committee Coordination Office, HHSC
Department of State Health Services Updates – Imelda Garcia, MPH Associate Commissioner of Laboratory and Infectious Disease Services
- Organizational changes
- Introduction of Josh Hutchinson, DSHS Central Pharmacy
- Exceptional item update
TB/HIV/STD Section Updates - Felipe Rocha, MSSW, Director TB/HIV/STD Section
- THMP Budget report
- Moving Forward Together meeting summary
THMP Update - Rachel Sanor, THMP Manager
- Rules change
- Projections and demographic information
- Long-lasting injection medication update
Procedure for Election of New Officers – Sallie Allen, Advisory Committee Coordination Office, HHSC
Sub-Committee Reports
- Formulary Sub-committee – Natalie Vanek, M.D.
- Governance/Data – Nancy Miertschin
- Eligibility – Frank Rosas
Public Comment – Sallie Allen, Advisory Committee Coordination Office, HHSC
Action items and agenda topics for next scheduled meeting November 5, 2021 – Natalie Vanek, M.D., Committee Chair
Adjourn – Natalie Vanek, M.D., Committee Chair

Public Comment: The Department of State Health Services (DSHS) welcomes public comments pertaining to topics related to the Texas HIV Medication Program. Members of the public who would like to provide public comment are asked to complete a Public Comment Form at: https://texashhsmeetings.org/HIVMAC_PCReg_July2021.

Members of the public who would like to provide written public comment to DSHS may email Mary Richards, at Mary.Richards@dshs.texas.gov no later than 5:00 p.m. Wednesday, July 28, 2021. Please include your name and the organization you are representing, or that you are speaking as a private citizen. Staff will not read written comments aloud during the meeting, but comments will be forwarded to State staff and committee members for their consideration. Comments should not include confidential information or protected health information.

If you would like to register to provide oral comments, please mark the correct box on the Public Comment form. Instructions for providing oral comment will be emailed to you. Registration must be completed no later than 5:00 p.m., Wednesday, July 28, 2021. Members of the public may also use the Microsoft Teams Live Event Q&A section during the meeting to submit a request to provide public comment. The request must contain your name and the organization you are representing, or that you are speaking as a private citizen, and your direct phone number. Do not include confidential information or protected health information in comments.

Public comment is limited to 3 minutes. Each speaker must state their name and either the organization they are representing or that they are speaking as a private citizen. Public members who are using handouts are asked to provide an electronic copy in accessible PDF format. Handouts are limited to two (2) pages (paper size: 8.5” by 11”, one side only). Handouts must be emailed to DSHS staff immediately after registering and include the name of the person who will be commenting. Do not include confidential information or protected health information in handouts. Staff will not read handouts aloud during the meeting, but handouts will be provided to Committee members and State staff. It is not permissible for public speakers to interject or ask questions to Committee members during the rest of the meeting.

Contact: Questions regarding agenda items, content, or meeting arrangements should be directed to Mary Richards, Pharmacy Coordinator, Department of State Health Services, at Mary.Richards@dshs.texas.gov or via phone at 1-800-255-1090.

This meeting is open to the public. No reservations are required, and there is no cost to attend this meeting.

People with disabilities who wish to attend the meeting and require assistive technology or services should contact Mary Richards, at Mary.Richards@dshs.texas.gov, or 800-255-1090 at least 72 hours prior to the meeting so that appropriate arrangements can be made.